SJ Medical
SJ Medical
The global Drug Coated Balloon (DCB) market is undergoing a transformative shift in interventional cardiology and peripheral vascular therapy. Driven by the philosophy of "Leave Nothing Behind," DCBs are increasingly preferred over traditional Drug-Eluting Stents (DES) for specific indications like in-stent restenosis (ISR) and small vessel disease. As a leading Drug Coated Balloon factory, we observe a significant CAGR growth of over 10% annually, particularly in the Asia-Pacific and European regions.
The industrial status of DCB manufacturing has evolved from basic coating applications to sophisticated nanotechnology. Modern OEM/ODM exporters must now master the balance of drug-excipient formulations (typically using Paclitaxel or Sirolimus) to ensure optimal transfer to the arterial wall within 30-60 seconds of inflation. This precision engineering is what distinguishes top-tier manufacturers in the global supply chain.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
SJ Medical operates a modern manufacturing facility with a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
Supported by a highly experienced technical team with decades of medical device industry experience, maintaining strict quality control and continuous improvement.
We hold CE certification, ISO 13485 quality management system certification, and CFDA approval, ensuring global compliance.
Hospitals and clinics are shifting toward drug-coated technologies that minimize chronic inflammation. We provide customized OEM solutions that meet regional regulatory requirements in EU, SEA, and Middle East.
As a China-based manufacturer, we offer the dual advantage of high-tier technology and cost-efficiency. Our supply chain resilience ensures stable delivery for high-volume international exporters.
Whether it's for Diabetic Foot treatment in Europe or CAD management in Asia, our DCB and PTA catheters are designed for diverse clinical scenarios and anatomical challenges.
SJ Medical focuses on the development of vascular interventional devices designed for both coronary and peripheral procedures. Its product range integrates interventional access systems, diagnostic catheters, and therapeutic devices, forming a complete solution for minimally invasive vascular treatments. Each product is developed with an emphasis on precision, safety, and clinical performance.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. The company continues to expand its international footprint and strengthen its global presence.
The core expertise of an OEM Drug Coated Balloon exporter lies in the coating homogeneity. Our proprietary coating technology utilizes a matrix that protects the drug (Paclitaxel) during transit through the vasculature, ensuring that the crystalline drug only releases upon balloon contact with the lesion. This reduces systemic toxicity while maximizing therapeutic concentration at the target site.
DCBs have revolutionized the treatment of Lower Extremity Artery Disease (LEAD) and small coronary vessels. By avoiding the permanent metallic cage of a stent, DCBs preserve the natural vasomotion of the vessel. This is particularly crucial for pediatric patients or locations subject to high mechanical stress, such as the popliteal artery.
SJ Medical leverages China's advanced manufacturing infrastructure to provide high-precision interventional devices. Our internal QC protocols exceed international standards, offering a 99.9% success rate in balloon crossability and inflation stability. By choosing a Chinese factory with deep R&D roots like ours, global distributors gain access to premium technology with competitive commercial terms.
